Prediction Case File
YouTubeEvaluation Complete

Ranking Every Big Tech Stock: Best to Worst

3 extracted signals · 3 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
27 Sept 2026, 13:47 UTC
Recorded by Tahlil Plus
27 Sept 2026, 14:56 UTC
Video preview for Ranking Every Big Tech Stock: Best to Worst
Source overview

AI-generated source summary

The analysis provided a ranking of tech stocks based on their current market performance and future prospects. Amazon (AMZN) is identified as a strong buy due to its consistent growth and operational efficiency, with a target price of $250 and a fail bound at $248. Broadcom (AVGO) is also considered a strong buy, trading at $352.81 with a target of $360 and a fail bound at $345, driven by its significant year-to-date gains and strong growth metrics. Alphabet (GOOGL) is placed in the 'wait' category, currently trading at $343.92. While its earnings growth is projected to remain robust, its valuation at 25x forward P/E is considered high, leading to a target of $350 but with a wider fail bound at $340, suggesting a wait-and-see approach.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
3
Extracted from this source
Open
0
Still being tracked
Successful
1
Resolved successfully
Failed
2
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
33.33%
3 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    3 eligible signals linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  7. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
355
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail